Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Phase Ib/II Trial of Preoperative Radiotherapy Combined With Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma

NCT05774275 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05774275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05774275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Phase Ib/II Trial of Preoperative Radiotherapy Combined With Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
Lead sponsor
Fudan University
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 25, 2022
Completion date
August 24, 2029
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk localized soft tissue sarcoma